Treatment controversy among major challenges for central serous chorioretinopathy

KOLOA, Hawaii — Lack of a consensus classification, overlapping pathophysiologic explanations and controversy over treatment make central serous chorioretinopathy “scream inducing,” according to a speaker.
“These patients often have systemic hypertension and a history of excess cortisol, whether internal from things like Cushing’s syndrome or external from things like exogenous steroid use,” Roger A. Goldberg, MD, MBA, said at Hawaiian Eye 2023. “Interestingly, acute central serous doesn’t really lead to chronic CSC. It’s like two different

Full Story →